MLRG Performance — iShares Morningstar U.S. Equity ETF
Data updated: 2026-09-25
MLRG returned +10.12% year to date and +19.11% over one year to Jul 2026. Annualised returns are +19.36% over 3 years and +12.27% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $170, against $153 for the category, and to $119 over one year, against $116. Volatility over the past three years was 13.34% a year. In the 12 months to Jul 2026 the fund lost a net $4.6M, and assets reached $1.27B.
MLRG Growth of $100
What $100 invested in iShares Morningstar U.S. Equity ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | MLRG | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $119 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $170 | $153 |
| 5 years (Aug 2021 – Jul 2026) | $178 | $159 |
| Since data start (Aug 2019 – Jul 2026) | $273 | $226 |
MLRG Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.12% |
| 1 year | +19.11% |
| 3 years (annualised) | +19.36% |
| 5 years (annualised) | +12.27% |
MLRG Annual Returns
Calendar-year total returns of iShares Morningstar U.S. Equity ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +10.12% |
| 2025 | +17.64% |
| 2024 | +25.04% |
| 2023 | +26.88% |
| 2022 | −19.50% |
| 2021 | +23.96% |
| 2020 | +19.42% |
| 2019 (Aug–Dec) | +11.37% |
MLRG Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.3% | −0.8% | −4.9% | +10.6% | +5.4% | −0.8% | −0.3% | — | — | — | — | — |
| 2025 | +3.1% | −1.6% | −5.9% | −0.5% | +6.5% | +5.1% | +2.3% | +2.0% | +3.6% | +2.3% | 0.0% | 0.0% |
| 2024 | +1.6% | +5.5% | +3.1% | −4.1% | +4.8% | +3.5% | +1.2% | +2.4% | +2.1% | −0.8% | +6.2% | −2.6% |
| 2023 | +6.6% | −2.4% | +3.4% | +1.3% | +0.6% | +6.7% | +3.4% | −1.7% | −4.7% | −2.3% | +9.4% | +4.7% |
| 2022 | −5.8% | −2.8% | +3.4% | −9.0% | −0.2% | −8.4% | +9.3% | −3.9% | −9.3% | +7.9% | +5.5% | −5.9% |
| 2021 | −2.2% | +1.7% | +4.0% | +5.4% | +0.4% | +2.7% | +2.2% | +2.9% | −4.7% | +6.9% | −1.2% | +4.0% |
| 2020 | +0.5% | −8.9% | −12.9% | +11.4% | +5.0% | +2.3% | +7.5% | +7.9% | −3.4% | −3.8% | +10.7% | +4.9% |
| 2019 | — | — | — | — | — | — | — | −1.1% | +1.9% | +2.3% | +4.3% | +3.5% |
MLRG Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 13.34%
- 3-year Sharpe ratio: 1.11 (vs 4.5% risk-free rate)
- Best month: +10.62% (Apr 2026)
- Worst month: −5.87% (Mar 2025)
MLRG Fund Flows
Monthly money in and out of iShares Morningstar U.S. Equity ETF, from SEC Form N-PORT.
- 12-month net flow: −$4.6M
- 12-month gross sales (incl. reinvestments): $38.6M
- Sales ÷ redemptions: 0.89×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $10.3M | $0 | $10.3M |
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $10.3M | −$10.3M |
| Apr 2026 | $0 | $9.4M | −$9.4M |
| Mar 2026 | $14.0M | $0 | $14.0M |
| Feb 2026 | $0 | $19.0M | −$19.0M |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $4.7M | $0 | $4.7M |
| Nov 2025 | $0 | $4.5M | −$4.5M |
| Oct 2025 | $9.5M | $0 | $9.5M |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
MLRG Assets Under Management
Net assets of iShares Morningstar U.S. Equity ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.27B |
| 2026-04-30 | $1.22B |
| 2026-01-31 | $1.19B |
| 2025-10-31 | $1.18B |
| 2025-07-31 | $1.08B |
| 2025-04-30 | $937.82M |
| 2025-01-31 | $1.21B |
| 2024-10-31 | $1.13B |
| 2024-07-31 | $935.38M |
| 2024-04-30 | $857.81M |
| 2024-01-31 | $834.83M |
| 2023-10-31 | $725.82M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.